AI can speed up drug discovery but don't expect it to cure cancer, yet

AI has demonstrated an ability to describe the contours of proteins that play a role in disease, comb vast chemical libraries for promising compounds, and improve the design and pace of clinical trials. Here's a closer look at the status of integrating AI into drug discovery, and the road ahead. Read more.

By Casey Ross

Adobe

HHS leaves vacant more than half the slots on a key vaccine advisory panel

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. Read more.

By Helen Branswell

Photo illustration: STAT; Photo: Adobe

A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit

Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that's when Lin says one of the Texas institute's most powerful researchers interfered. Read more.

By Angus Chen and Jonathan Wosen

More great reads from STAT this week

Supreme Court to weigh whether Covid misinformation is protected speech
Opinion: Aduhelm was a mess — and it could happen again
Health care developers are impressed by Apple Vision Pro, but they aren't diving head first
Could testosterone be a useful treatment for menopause?
Mystery of allergic memory gets closer to answer: a rare group of B cells